Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US

Johnson & Johnson (NYSE:JNJ) is one of the 10 Best and Cheap Stocks to Buy Now. On June 19, Johnson & Johnson (NYSE:JNJ) announced the launch of two new plating systems in the United States under its VOLT platform, called Distal Radius and Proximal Humerus 3.5 Plating Systems.

The systems are designed to treat the two most commonly fractured bones, which are the distal radius near the wrist and the proximal humerus near the shoulder. These injuries are common in people above 65 years old. Johnson & Johnson (NYSE:JNJ) designed these systems in collaboration with the Hand Expert Group from the AO Technical Commission. The new plate has a new shape that sits more distally on the bone fragments and has a less prominent profile to reduce soft tissue irritation, thereby improving the overall comfort and healing process.

Johnson & Johnson (NYSE:JNJ) highlighted that the systems fill in a critical gap in the current treatment of fractures. The systems are now readily available across the United States. Johnson & Johnson (NYSE:JNJ) is an international global healthcare company. The company operates through two segments including innovative medicine and MedTech.

While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.